The coming of age of ultrasound-guided percutaneous ethanol ablation of selected neck nodal metastases in well-differentiated thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 9, 2011, Pages 2717-2720

  Hay, Ian D ^a   Charboneau, J William ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; RADIOACTIVE IODINE;

CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CERVICAL LYMPH NODE; DIFFERENTIATED THYROID CANCER; EDITORIAL; HEALTH CARE COST; HOARSENESS; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; PRIORITY JOURNAL; RADIATION DOSE; STEREOTACTIC TREATMENT; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TREATMENT INDICATION; TREATMENT RESPONSE; TUMOR ABLATION; TUMOR BIOPSY; ULTRASOUND GUIDED PERCUTANEOUS ETHANOL ABLATION; ULTRASOUND THERAPY; VOICE CHANGE;

CARCINOMA, PAPILLARY; ETHANOL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; THYROID NEOPLASMS;

EID: 80052538043     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2196     Document Type: Editorial

References (20)

1. Schlumberger M.J., Filetti S., Hay I.D. 2011 Non-toxic diffuse and nodular goiter and thyroid neoplasia. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams textbook of endocrinology. 12th ed. Philadelphia: Elsevier Saunders Company; 440-478
2. Grebe S.K., Hay I.D. 1996 Thyroid cancer nodal metastases: Biological significance and therapeutic considerations. Surg Oncol Clin N Am 5:43-63 (Pubitemid 26047382)
3. Grebe S.K., Hay I.D. 1997 Follicular cell-derived thyroid carcinoma. Cancer Treat Res 89:91-140
4. Torlantano M., Attard M., Crocetti U., Tumino S., Bruno R., Costante G, D'Azzò G, Meringolo D, Ferretti E, Sacco R, Arturi F, Filetti S 2004 Follow-up of low risk patients with papillary thyroid cancer; role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 89:3402-3407
5. Cooper D.S., Doherty G.M., Haugen B.R., Hauger B.R., Kloos R.T., Lee S.L., Mandel S.J., Mazzaferri E.L., McIver B., Pacini F., Schlumberger M., Sherman S.I., Steward D.L., Tuttle R.M. 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
6. Rondeau G., Tuttle R.M. 2011 Similarities and differences in follicular cell-derived thyroid cancer management guidelines used in Europe and the United States. Semin Nucl Med 41:89-95
7. Al-Saif O., Farrar W.B., Bloomston M., Porter K., Ringel M.D., Kloos R.T. 2010 Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab 95:2187-2194
8. Schuff K.G. 2011 Management of recurrent/persistent papillary thyroid carcinoma: Efficacy of the surgical option. J Clin Endocrinol Metab 96:2038-2039
9. Yim J.H., Kim W.B., Kim E.Y., Kim W.G., Kim T.Y., Ryu J.S., Gong G., Hong S.J., Shong Y.K. 2011 The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab 96:2049-2056
10. Kim J.H., Kim M.S., Yoo S.Y., Lim S.M., Lee G.K., Yi K.H. 2010 Stereotactic body radiotherapy for refractory cervical lymph node recurrence of nonanaplastic thyroid cancer. Otolaryngol Head Neck Surg 142:338-343
11. Heilo A., Sigstad E., Fagerlid K.H., Haskjold O.I., Groholt K.K., Berner A., Bjoro T., Jorgensen L.H. 2011 Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma. J Clin Endocrinol Metab 96:2750-2755
12. Lewis B.D., Hay I.D., Charboneau J.W., McIver B., Reading C.C., Goellner J.R. 2002 Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. AJR 178:699-704 (Pubitemid 34178153)
13. Monchik J.M., Donatini G., Iannucilli J., Dupuy D.E. 2006 Radiofrequency ablation and percutaneous ethanol injection for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 244:296-304
14. Lim C.Y., Yun J.S., Lee J., Nam K.H., Chung W.Y., Park C.S. 2007 Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma. Thyroid 17:347-350 (Pubitemid 46776139)
15. Kim B.M., Kim M.J., Kim E.K., Park S.I., Park C.S., Chung W.Y. 2008 Controlling recurrent papillary thyroid carcinoma in the neck by ultrasonography-guided percutaneous ethanol injection. Eur Radiol 18:835-842 (Pubitemid 351447779)
16. Charboneau J.W., Hay I.D., Van Heerden J.A. 1988 Persistent primary hyperparathyroidism: Successful ultrasound-guided percutaneous ethanol ablation of an occult adenoma.MayoClin Proc 63:913-917
17. Livraghi T., Paracchi A., Ferrari C., Bergonzi M., Garavaglia G., Raineri P., Vettori C. 1990 Treatment of autonomous thyroid nodules with percutaneous ethanol injection: Preliminary results. Work in progress. Radiology 175:827-829 (Pubitemid 20191953)
18. Goletti O., Lenziardi M., DeNegri F., Fiorini I., Lippolis P.V., Cristofani E., Di Coscio G., Secia M., Cavina E. 1993 Inoperable thyroid carcinoma: Palliation with percutaneous injection of ethanol. Eur J Surg 159:639-641 (Pubitemid 24002268)
19. Grant C.S., Stulak J.M., Thompson G.B., Richards M.L., Reading C.C., Hay I.D. 2010 Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006. World J Surg 34:1239-1246
20. Hay I.D. 2006 Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma. J Surg Oncol 94:692-700 (Pubitemid 44902068)